Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types
| dc.contributor.author | Ilhan, N | |
| dc.contributor.author | Ilhan, N | |
| dc.contributor.author | Deveci, F | |
| dc.date.accessioned | 2026-08-12T17:29:54Z | |
| dc.date.issued | 2004 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Objectives: VEGF is one of the key factors in tumor angiogenesis that may be involved in tumor growth and metastasis. VEGF receptor, a naturally occurring soluble form of the VEGFR-1 (sVEGFR-1. flt-1), is produced by endothelial cells by differential splicing of the flt-1 gene, and is a negative counterpart of the VEGF signaling pathway. Design and Methods: We investigated the levels of VEGF and sVEGFR-1, a known intrinsic inhibitor of VEGF, in 42 patients with various types of lung cancers before beginning treatment and 18 healthy subjects. \ Results: Serum sVEGFR-1 levels (mean +/- SD, pg/ml) were 465.17 +/- 158.34 in patients and were significantly higher than those of the healthy subjects (156.39 +/- 89.17) (P < 0.0001). Serum VEGF levels of patients (449.48 +/- 175.54 pg/ml) were significantly higher in patients than in healthy subjects (77.06 +/- 47.26 pg/ml) (P < 0.0001). Conclusions: We conclude that increased sVEGFR-1 and VEGF levels are important parameters in lung cancers. (C) 2004 The Canadian Society of Clinical Chemists. All rights reserved. | |
| dc.identifier.doi | 10.1016/j.clinbiochem.2004.03.012 | |
| dc.identifier.endpage | 845 | |
| dc.identifier.issn | 0009-9120 | |
| dc.identifier.issn | 1873-2933 | |
| dc.identifier.issue | 9 | |
| dc.identifier.orcid | 0000-0001-9997-0418 | |
| dc.identifier.orcid | 0000-0001-9997-0418 | |
| dc.identifier.orcid | 0000-0002-0208-8929 | |
| dc.identifier.orcid | 0000-0002-0208-8929 | |
| dc.identifier.pmid | 15329326 | |
| dc.identifier.scopus | 2-s2.0-4344611148 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 840 | |
| dc.identifier.uri | https://doi.org/10.1016/j.clinbiochem.2004.03.012 | |
| dc.identifier.uri | https://hdl.handle.net/11508/55888 | |
| dc.identifier.volume | 37 | |
| dc.identifier.wos | WOS:000223841800017 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science Ltd | |
| dc.relation.ispartof | Clinical Biochemistry | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | VEGF | |
| dc.subject | sVEGFR-1 | |
| dc.subject | lung cancer | |
| dc.title | Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types | |
| dc.type | Article |







